About Macro*World
     My Macro*World    Portfolio   Markets   Research   Economic Help | Back To Calibre  

 
Ticker/Name
Search


By Industry
By Name
By Family
By Name
By Objective
Industry Groups
U.S. Markets
Non-U.S. Markets
Custom
Stock
Industry
Money Market Fund
Currency
Interest Rate
National Overview
Office Vacancy Rate
Industrial Vacancies
Bean Complex
Currency
Energy
Financials
Food & Fiber
Grains & Wheat
Index
LiveStock
Metal

Back
Research from University of Texas has provided new information about tissue engineering

Released : Thursday, November 20, 2008 8:01 PM

2008 NOV 27 - (NewsRx.com) -- According to recent research published in the Journal of Biomedical Materials Research Part B - Applied Biomaterials, "Two different approaches were used to fabricate porous scaffolds, and their in vitro drug releasing characteristics were examined (see also Tissue Engineering). In the first method, a poly(I-lactic acid) (PLLA) solution and poly(vinyl alcohol) (PVA) + acetaminophen solution was homogenized."

"The emulsion was then blended with a PLLA solution in chloroform. The resultant emulsion was freeze-dried to form porous scaffolds. Various combinations were obtained by varying homogenizer speed and blender speed, and by varying the concentration of PVA and acetaminophen solutions. The in vitro drug-release study was performed for 6 days in a phosphate buffer. The influence of structure, porosity, and drug concentration of the scaffolds on drug-release rate was examined using design of experiments. In the second approach, scaffolds were prepared in layered constructs, with either a three-layered or five-layered structure. The PVA + acetaminophen solution was blended with PLLA solution using a blender. The drug-release study was performed for 19 days," wrote M. Uttarwar and colleagues, University of Texas.

The researchers concluded: "The effect of drug concentration, blender speed, and the thickness of the layers on drug-release rate was examined."

Uttarwar and colleagues published their study in the Journal of Biomedical Materials Research Part B - Applied Biomaterials (Fabrication of porous, drug-releasing, biodegradable, polymer scaffolds for sustained drug release. Journal of Biomedical Materials Research Part B - Applied Biomaterials, 2008;87B(1):121-131).

For additional information, contact P. Aswath, University of Texas Arlington, Dept. of Materials Science & Engineering, Arlington, TX 76019, USA.

The publisher's contact information for the Journal of Biomedical Materials Research Part B - Applied Biomaterials is: Wiley-Liss, Division John Wiley & Sons Inc., 111 River St., Hoboken, NJ 07030, USA.

Copyright 2008 Blood Weekly via NewsRx.com


Provider:
NewsRx.com / Blood Weekly

Keywords:
Alternative Technologies, Molecular & Cellular Biology, Biotechnology Industry Trends & Policy, Biomaterials, North American Biotechnology, Biopharmaceuticals, Biotechnology, U.S. Business News, Business News, Chemicals, General Clinical Healthcare

Quotes delayed at least 15 minutes for Nasdaq, and at least 20 minutes otherwise.

Securities and Insurance Products:
Not insured by FDIC or any Federal Government Agency
May Lose Value
Not a Deposit of or Guaranteed by the Bank or any Bank affiliate

Supplemental Information Provided By: Dialog, Morningstar, Inc., Comstock and FX Quotes? a GTIS Corporation.

? Links to third-party sites are provided for your convenience. Such sites are not within our control and may not follow the same privacy, security, or accessibility standards as ours. Wachovia neither endorses nor guarantees offerings of the third party providers, nor is Wachovia responsible for the security, content or availability of third-party sites, their partners, or advertisers.
? 2008 Wachovia Corporation. All rights reserved.